Biguanides enhance antifungal activity against Candida glabrata

Candida spp. are the fourth leading cause of nosocomial blood stream infections in North America. Candida glabrata is the second most frequently isolated species, and rapid development of antifungal resistance has made treatment a challenge. In this study, we investigate the therapeutic potential of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Shuying Xu, Marianela Feliu, Allison K. Lord, Daniel P. Lukason, Paige E. Negoro, Nida S. Khan, Zeina Dagher, Michael B. Feldman, Jennifer L. Reedy, Samantha N. Steiger, Jenny M. Tam, Alexander A. Soukas, David B. Sykes, Michael K. Mansour
Materialtyp: Artigo
Språk:Inglês
Publicerad: Taylor & Francis Group 2018-12-01
Serie:Virulence
Ämnen:
Candida
Candida glabrata
biguanide
drug resistance
metformin
minimum inhibitory concentration (MIC)
Länkar:http://dx.doi.org/10.1080/21505594.2018.1475798
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk